Results 31 to 40 of about 1,682,259 (274)

Polycystic Ovary Syndrome: Considerations About Therapeutic Strategies Choices from Fertile Life to Menopause

, 2021
Polycystic ovary syndrome (PCOS) is a very frequent endocrine disorder in women since it occurs in as many as 8–10% of women of reproductive age [1, 2]. Due to the multiple heterogeneity of the syndrome [3], there has been no agreement on the criteria on
Martina C., Tabatha P., Alba M., Veronica T., Giulia D., Genazzani A. R., Fedora A., Genazzani A. D., Melania A.   +8 more
core   +1 more source

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome : a systematic review and meta-analysis [PDF]

, 2012
Aims/hypothesis FTO gene single nucleotide polymorphisms (SNPs) have been shown to be associated with obesity-related traits and type 2 diabetes. Several small studies have suggested a greater than expected effect of the FTO rs9939609 SNP on weight in ...
Lerchbaum, E., Straczkowski, M., Tan, S., Wojciechowski, Piotr, B. Obermayer-Pietsch, Bendlova, B., Grigorescu, F., McCarthy, M. I., S. Franks, Rys, P., Goodarzi, M. O., Azziz, R., P. Lukasova, S. Tan, Azziz, Ricardo, F. Grigorescu, P. Rys, M. T. Malecki, J. Vcelak, M. I. McCarthy, null null, M. O. Goodarzi, B. Bendlova, Małecki, Maciej, Strauss III, J. F., Franks, S., Lukasova, P., M. Straczkowski, R. Azziz, A. Lipowska, K. G. Ewens, Kowalska, I., Malecki, M. T., Obermayer-Pietsch, B., Attaoua, R., R. Attaoua, J. F. Strauss, Wojciechowski, P., Barber, T. M., Ewens, K. G., Hinney, A., Strauss, J. F., III, P. Wojciechowski, McCarthy, Mark I., Vcelak, J., E. Lerchbaum, HASH(0x55a680537f60), T. M. Barber, I. Kowalska, Lipowska, A., A. Hinney, Franks, Stephen, Strauss, J. F., Ewens, Kathryn G., Hinney, Anke   +54 more
core   +1 more source

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy

International Journal of Endocrinology, 2018
Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without ...
Eduardo Spinedi, Daniel P. Cardinali
doaj   +1 more source

HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome

Journal of the Formosan Medical Association, 2019
Background/purpose: Genetic variant of HSD3B1 1245 is known to augment androgen production at peripheral tissue as skin. This study aimed to investigate whether women with polycystic ovary syndrome inheriting this variant exhibit specific androgenic ...
Yi-An Tu, Sung-Jan Lin, Pei-Lung Chen, Chia-Hung Chou, Chu-Chun Huang, Hong-Nerng Ho, Mei-Jou Chen   +6 more
doaj   +1 more source

Does AMH Reflect Follicle Number Similarly in Women with and without PCOS? [PDF]

PLoS ONE, 2016
Increased Anti-Mullerian Hormone in polycystic ovary syndrome, may be due to overactive follicles rather than reflect antral follicle count.Does Anti-Mullerian Hormone reflect antral follicle count similarly in women with or without polycystic ovary ...
Sverre C Christiansen, Tina B Eilertsen, Eszter Vanky, Sven M Carlsen   +3 more
doaj   +1 more source

Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]

, 1995
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
Roger, Müller, Burkhardt, Höss, Cornelia, Burkhardt Moller, Jacob, Karl, Thomas Strowitzki, Michael M. Weber, Kimmig, Rainer, Weber, Michael M., Engelhardt, Dieter, Luppa, Peter, A. Lob, Peter Luppa, Dieter Engelhardt, Karl Jacob, Cornelia H, Rainer Kimmig, Strowitzki, Thomas, Lobo, Rogerio A.   +18 more
core   +1 more source

Familial association of polycystic ovary syndrome (PCOS) in women attending the gynaecological endocrinology clinic at Groote Schuur Hospital [PDF]

, 2010
Includes bibliographical references (leaves 60-65).Polycystic ovary syndrome (PCOS) is the commonest endocrinopathy in women of reproductive age, affecting 5-10% of women in the general population.
Edelstein, Sascha
core   +1 more source

Controversies in the diagnosis of polycystic ovary syndrome

Therapeutic Advances in Reproductive Health, 2020
Polycystic ovary syndrome is a common endocrinological condition which is found to be prevalent in 5–10% of women of reproductive age. Historically, a combination of anovulation and androgen excess was considered a hallmark in the diagnosis of polycystic
Preetham Rao, Priya Bhide
doaj   +1 more source

GHRELIN AND INSULIN RESISTANCE IN A SAMPLE OF IRAQI WOMEN WITH POLYCYSTIC OVARY SYNDROME

The Iraqi Journal of Medical Sciences, 2016
Background: Polycystic ovary syndrome is associated with adiposity and metabolic changes predisposing to insulin resistance and diabetes mellitus. Ghrelin is an appetite-stimulating hormone, which acts through its receptor on the hypothalamus to regulate
Amal A. Hussein, Rayah S. Baban, Alaa G. Hussein   +2 more
doaj   +4 more sources

Relation of Vitamin D Deficiency in Women with Polycystic Ovarian Syndrome in Kirkuk

Al-Kitab Journal for Pure Sciences, 2023
Polycystic ovary syndrome is one of the most chronic diseases affecting women. Some studies indicate that the level of vitamin D is related to the development of polycystic ovary syndrome.
Sundus Abdul kaream Mardan, Jacklen Zaea Khoshaba, Salwa Saadoon   +2 more
doaj   +1 more source